EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating Immune and Endocrine Markers in Currently Drinking and Abstinent Individuals With Alcohol Use Disorder and Controls

Ryan E Tyler, Carlotta Vizioli, Jennifer J Barb, Mehdi Farokhnia, Lorenzo Leggio iD

Addiction Biology · 2025

DOI: 10.1111/adb.70039 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Addiction Biology, 2025. Verfasst von Ryan E Tyler und 4 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN) Section, Translational Addiction Medicine Branch, National Institute on Drug Abus…. Hauptthemen laut MEDLINE: Alcoholism, Alcohol Abstinence, Alcohol Drinking. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Peter G. Dodge Foundation, NIGMS NIH HHS, NIDA Intramural Research Program, NIH.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcohol use disorder (AUD) is associated with changes in endocrine and immune system function. This study is a secondary analysis aimed at investigating changes in circulating immune and endocrine biomarkers in blood samples from three groups: (1) healthy controls (HC, N = 12), (2) AUD—currently drinking, nontreatment seeking (CD, N = 9), and (3) AUD—abstinent, treatment‐seeking (AB, N = 10; abstinent for at least 6 weeks). We hypothesized that both immune and endocrine biomarker concentrations would be different in AUD groups compared to healthy controls. Immune biomarkers included IL‐8, IL‐18, CCL2, TNF‐α, IL‐1RA, IL‐6, and IL‐10. Endocrine biomarkers included brain‐derived neurotrophic factor (BDNF), glucagon‐like peptide 1 (GLP‐1), ghrelin, gastric inhibitory peptide (GIP), growth hormone, leptin, and insulin. Biomarker concentrations were compared between the three groups while controlling for age and sex, and associations between biomarker concentrations and behavioral measures were explored. IL‐8 concentrations were elevated in AB compared to CD and HC ( F (2,29) = 6.33, p = 0.006, ƞ p 2 = 0.318). BDNF concentrations were lower in AB compared to HC ( F (2,30) = 4.34, p = 0.02, ƞ p 2 = 0.266). GLP‐1 concentrations were higher in AB compared to HC ( F (2,25) = 4.22, p = 0.03, ƞ p 2 = 0.287). Exploratory analyses in combined groups showed that measures of past drinking, AUD severity, and anxiety/depression positively correlated with IL‐18 and TNF‐α and negatively correlated with BDNF. These results demonstrate that circulating concentrations of both immune and endocrine proteins are altered in abstinent individuals with a history of severe AUD (AB group) compared to healthy controls. In contrast, no group differences were observed for any biomarker between the nontreatment seeking, currently drinking people with AUD and the HC group. Our findings highlight the importance of accounting for AUD severity, comorbidities, and treatment‐seeking status, especially when studying alcohol‐related biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlcoholismAlcohol AbstinenceAlcohol DrinkingHumansMaleBiomarkersFemaleAdultBrain-Derived Neurotrophic FactorGhrelinMiddle AgedGlucagon-Like Peptide 1LeptinGastric Inhibitory PolypeptideInsulinTumor Necrosis Factor-alphaCase-Control StudiesInterleukin-8Interleukin-18Chemokine CCL2Interleukin-10

Stichwörter der Autor:innen

BDNFGLP‐1IL‐18IL‐8abstinencebiomarkers

Substanzen

BiomarkersBrain-Derived Neurotrophic FactorGhrelinGlucagon-Like Peptide 1LeptinGastric Inhibitory PolypeptideInsulinBDNF protein, humanTumor Necrosis Factor-alphaInterleukin-8

Autor:innen und Institutionen

  • Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN) Section, Translational Addiction Medicine Branch, National Institute on Drug Abuse Intramural Research Program and National Institute on Alcohol Abuse…
  • National Institute of General Medical Sciences, Bethesda, Maryland, USA.
  • Interoceptive Disorders Unit, Office of the Clinical Director, National Institute of Neurological Disorders and Stroke, NIH, Bethesda, Maryland, USA.
  • Translational Biobehavioral and Health Disparities Branch, Clinical Center, NIH, Bethesda, Maryland, USA.

ORCID-Profile: Lorenzo Leggio

Förderung

  • Peter G. Dodge Foundation
  • NIGMS NIH HHS
  • NIDA Intramural Research Program, NIH
  • NIAAA Division of Intramural Clinical and Biological Research, NIH
  • National Institute of General Medical Sciences, NIH
  • Center on Compulsive Behavior Fellowship, NIH
  • Intramural NIH HHS
  • National Institute of General Medical Sciences

Zitieren

APA

Tyler, R. E., Vizioli, C., Barb, J. J., Farokhnia, M., & Leggio, L. (2025). Circulating Immune and Endocrine Markers in Currently Drinking and Abstinent Individuals With Alcohol Use Disorder and Controls. Addiction Biology. https://doi.org/10.1111/adb.70039

Vancouver

Tyler RE, Vizioli C, Barb JJ, Farokhnia M, Leggio L. Circulating Immune and Endocrine Markers in Currently Drinking and Abstinent Individuals With Alcohol Use Disorder and Controls. Addiction Biology. 2025. doi:10.1111/adb.70039

BibTeX
@article{Tyler2025,
  author = {Tyler, Ryan E and Vizioli, Carlotta and Barb, Jennifer J and Farokhnia, Mehdi and Leggio, Lorenzo},
  title = {Circulating Immune and Endocrine Markers in Currently Drinking and Abstinent Individuals With Alcohol Use Disorder and Controls},
  journal = {Addiction Biology},
  year = {2025},
  doi = {10.1111/adb.70039}
}
Kostenlos starten →